InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (8 ops.)
Explore the detailed record of transactions filed by Hamilton James C, Chief Medical Officer. Officer active across 1 companies, notably Arrowhead Pharmaceuticals, INC.. Cumulatively, 10 reports have been published. Total volume traded: €4.1m. The latest transaction was disclosed on 23 April 2026 — Cession. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations10 total
US$641,91010,000 shares@ US$64.1910.0059% mcap31.3% of flow
Common Stock
SEC:0001830755-26-000007·
€641,91010,000 shares@ €64.1910.0059% mcap15.6% of flow
Common Stock
SEC:0001830755-26-000007:0·
US$241,9854,625 shares@ US$52.3210.0022% mcap11.8% of flow
Common Stock
SEC:0001830755-26-000002·
€241,9854,625 shares@ €52.3210.0022% mcap5.9% of flow
Common Stock
SEC:0001830755-26-000002:0·
US$596,55420,000 shares@ US$29.82770.0055% mcap29.1% of flow
Common Stock
SEC:0001830755-25-000011·
€596,55420,000 shares@ €29.82770.0055% mcap14.5% of flow
Common Stock
SEC:0001830755-25-000011:0·
€571,5509,955 shares@ €57.41340.0053% mcap27.9% of flow
Common Stock
SEC:0001209191-22-002284·
€571,5509,955 shares@ €57.41340.0053% mcap13.9% of flow
Common Stock
SEC:0001209191-22-002284:0·
055,000 shares0
Common Stock
SEC:0001209191-22-001313·
055,000 shares0
Common Stock
SEC:0001209191-22-001313:0·
10 of 10 declarations
About Hamilton James C
James C. Hamilton is the Chief Medical Officer at Arrowhead Pharmaceuticals, Inc. He oversees clinical activities and drug development strategies. His role is essential in ensuring that the products developed meet safety and efficacy standards while contributing to innovation in the pharmaceutical field.
